Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

50 recalls · Class I, newest first

Class I · High risk

Hydromorphone HCl in 0.9% sodium chloride

Incorrect Product Formulation; Firm's customer resource center (CRC) statement indicates that the product is sulfite free, however the product is produced with a raw material that contains sulfite

Terminated Other PharMEDium Services, LLC NDC 61553-352-78 D-1488-2019
Class I · High risk

Pecgen DMX Cough Suppressant Expectorant

Labeling: Incorrect Instructions; The product has been found to provide incorrect dosage information on its label due to a typographical error. The drug facts label incorrectly states children 6 to under 2 years of age, 1 teaspoonful every 4 hours, not to exceed 4 teaspoonfuls in 24 hours or directed by physician. The label should state children 6 to under 12, 1 teaspoonful every 4 hours, not to exceed 4 teaspoonfuls in 24 hours or as directed by physician. Additionally, the label does not advise consumers to consult a doctor for children under 2 years of age.

Terminated Labeling / mix-up Novis PR, Inc. NDC 52083-630-16 D-1395-2019
Class I · High risk

Amikacin Sulfate Injection

Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .

Terminated Sterility / contamination Heritage Pharmaceuticals, Inc. NDC 23155-290-32 D-1398-2019
Class I · High risk

Prochlorperazine Edisylate Injection

Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .

Terminated Sterility / contamination Heritage Pharmaceuticals, Inc. NDC 23155-294-31 D-1397-2019
Class I · High risk

Promacta (eltrombopag)

Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.

Terminated Cross-contamination Novartis Pharmaceuticals Corp. NDC 0078-0972-61 D-1309-2019
Class I · High risk

The Beast

Marketed without an Approved NDA/ANDA: The Beast contains undeclared sildenafil which was discovered through FDA analysis.

Terminated Chemical / undeclared Stiff Boy LLC D-1321-2019
Class I · High risk

Titanium 4000

Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.

Terminated Chemical / undeclared D.B.P. Distribution D-1292-2019
Class I · High risk

FENTANYL Transdermal System

Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.

Terminated Labeling / mix-up Alvogen, Inc NDC 47781-423-47 D-1277-2019
Class I · High risk

Aphrodisiac Platinum 40000

Marketed without an approved NDA/ANDA: FDA analysis has found the product to be tainted with sildenafil

Terminated Chemical / undeclared Select Distributions LLC D-1344-2019
Class I · High risk

Kopi Jantan Tradisional Natural Herbs Coffee

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to be tainted with undeclared sildenafil and tadalafil, two FDA approved drugs for the treatment of male erectile dysfunction, making this an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.

Terminated Chemical / undeclared Brian P. Richardson D-1206-2019
Class I · High risk

Blue Fusion Capsules

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared ingredients: Sildenafil, Tadalafil, desmethyl carbodenafil, dithiodesmethyl carbodenafil, scutellarin, and daidzein.

Terminated Chemical / undeclared Ata International Inc D-1085-2019
Class I · High risk

LEOPARD Miracle Honey packaged in a wooden box

Marketed Without An Approved NDA/ANDA: product tainted with undeclared sildenafil, an FDA approved drug for the treatment of male erectile dysfunction. The presence of sildenafil in Leopard Miracle Honey renders it an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.

Terminated Chemical / undeclared USA LESS Inc. D-1135-2019
Class I · High risk

Golean DETOX capsules

Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain undeclared sibutramine and phenolphthalein. Sibutramine is an appetite suppressant that was withdrawn from the US market due to safety concerns. Phenolphthalein was once an ingredient used in over-the-counter laxatives, but because of concerns of carcinogenicity is not currently approved for marketing in the US. The presence of sibutramine and phenolphthalein in this product renders it an unapproved drug for which the safety and efficacy has not been established and, therefore, subject to recall.

Terminated Nitrosamine impurity Golean Detox US D-1009-2019
Class I · High risk

Maeng Da Kratom

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS: Analysis of samples were positive for Salmonella.

Terminated Microbial contamination Todd Holiday dba Sunstone Organics D-0989-2019
Class I · High risk

White Vein Kratom

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS: Analysis of samples were positive for Salmonella.

Terminated Microbial contamination Todd Holiday dba Sunstone Organics D-0988-2019
Class I · High risk

White Vein Kratom

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS: Analysis of samples were positive for Salmonella.

Terminated Microbial contamination Todd Holiday dba Sunstone Organics D-0987-2019
Class I · High risk

Maeng Da Kratom

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS: Analysis of samples were positive for Salmonella.

Terminated Microbial contamination Todd Holiday dba Sunstone Organics D-0986-2019

Recalls by year